Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge

Infection and Immunity

Volumn 75, Issue 10, 2007, Pages 4923-4932

  Kahl McDonagh, M M ^a   Arenas Gamboa, A M ^a   Ficht, T A ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BAGG ALBINO MOUSE; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENE DELETION; INFECTION RATE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AEROSOLS; ANIMALS; BACTERIAL VACCINES; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; COLONY COUNT, MICROBIAL; FEMALE; GENE DELETION; LIVER; LUNG; MICE; MICE, INBRED BALB C; SPLEEN; VACCINES, ATTENUATED;

EID: 34848916371     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00451-07     Document Type: Article

References (31)

1. Bhattacharjee, A. K., M. J. Izadjoo, W. D. Zollinger, M. P. Nikolich, and D. L. Hoover. 2006. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Infect. Immun. 74:5820-5825.
2. Bhattacharjee, A. K., L. Van de Verg, M. J. Izadjoo, L. Yuan, T. L. Hadfield, W. D. Zollinger, and D. L. Hoover. 2002. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein. Infect. Immun. 70:3324-3329.
3. Bossi, P., A. Tegnell, A. Baka, F. Van Loock, J. Hendriks, A. Werner, H. Maidhof, and G. Gouvras. 2004. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Eur. Surveill. 9:E15-E16.
4. Campos, E., S. L. Cravero, L. Delgui, I. Mora, N. Kahn, A. I. Arese, and O. L. Rossetti. 2002. Brucella abortus INTA2, a novel strain 19 (Delta)bp26::luc (Delta)bmp18 double mutant lacking drug resistance markers. Vet. Microbiol. 87:1-13.
5. Davos, D. E., C. F. Cargill, M. R. Kyrkou, J. A. Jamieson, and G. E. Rich. 1981. Outbreak of brucellosis at a South-Australian abattoir. 2. Epidemiological investigations. Med. J. Aust. 2:657-660.
6. Edmonds, M. D., A. Cloeckaert, and P. H. Elzer. 2002. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis. Vet. Microbiol. 88:205-221.
7. Enright, F. M., L. N. Araya, P. H. Elzer, G. E. Rowe, and A. J. Winter. 1990. Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus. Vet. Immunol. Immunopathol. 26: 171-182.
8. Godfroid, J., A. Cloeckaert, J. P. Liautard, S. Kohler, D. Fretin, K. Walravens, B. Garin-Bastuji, and J. J. Letesson. 2005. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res. 36:313-326.
9. Guilloteau, L. A., J. Dornand, A. Gross, M. Olivier, F. Cortade, Y. L. Vern, and D. Kerboeuf. 2003. Nramp1 is not a major determinant in the control of Brucella melitensis infection in mice. Infect. Immun. 71:621-628.
10. Hoover, D. L., R. M. Crawford, L. L. Van De Verg, M. J. Izadjoo, A. K. Bhattacharjee, C. M. Paranavitana, R. L. Warren, M. P. Nikolich, and T. L. Hadfield. 1999. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MΔpurEK). Infect. Immun. 67:5877-5884.
11. Hughes, M. A., C. S. Green, L. Lowchyj, G. M. Lee, V. K. Grippe, M. F. Smith, Jr., L. Y. Huang, E. T. Harvill, and T. J. Merkel. 2005. MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling. Infect. Immun. 73:7535-7540.
12. Izadjoo, M. J., A. K. Bhattacharjee, C. M. Paranavitana, T. L. Hadfield, and D. L. Hoover. 2004. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M. Infect. Immun. 72:4031-4039.
13. Izadjoo, M. J., Y. Polotsky, M. G. Mense, A. K. Bhattacharjee, C. M. Paranavitana, T. L. Hadfield, and D. L. Hoover. 2000. Impaired control of Brucella melitensis infection in Rag1-deficient mice. Infect. Immun. 68:5314-5320.
14. Kahl-McDonagh, M. M., P. H. Elzer, S. D. Hagius, J. V. Walker, Q. L. Perry, C. M. Seabury, A. B. den Hartigh, R. M. Tsolis, L. G. Adams, D. S. Davis, and T. A. Ficht. 2006. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine 24:5169-5177.
15. Kahl-McDonagh, M. M., and T. A. Ficht. 2006. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice. Infect. Immun. 74:4048-4057.
16. McMurray, D. N., S. S. Allen, A. Jeevan, T. Lasco, H. Cho, T. Skwor, T. Yamamoto, C. McFarland, and T. Yoshimura. 2005. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis. Tuberculosis (Edinburgh) 85:295-301.
17. Mense, M. G., R. H. Borschel, C. L. Wilhelmsen, M. L. Pitt, and D. L. Hoover. 2004. Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta). Am. J. Vet. Res. 65:644-652.
18. Mense, M. G., L. L. Van De Verg, A. K. Bhattacharjee, J. L. Garrett, J. A. Hart, L. E. Lindler, T. L. Hadfield, and D. L. Hoover. 2001. Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis. Am. J. Vet. Res. 62:398-405.
19. Mielke, M. E. 1991. T cell subsets in granulomatous inflammation and immunity to L. monocytogenes and B. abortus. Behring Inst. Mitt 88:99-111.
20. Miller, C. D., J. R. Songer, and J. F. Sullivan. 1987. A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center. Am. Ind. Hyg. Assoc. J. 48:271-275.
21. Montaraz, J. A., and A. J. Winter. 1986. Comparison of living and non-living vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 53:245-251.
22. Pappas, G., P. Panagopoulou, L. Christou, and N. Akritidis. 2006. Biological weapons: Brucella as a biological weapon. Cell. Mol. Life Sci. 63:2229-2236.
23. Pappas, G., P. Papadimitriou, N. Akritidis, L. Christou, and E. V. Tsianos. 2006. The new global map of human brucellosis. Lancet Infect. Dis. 6:91-99.
24. Pilette, C., Y. Ouadrhiri, V. Godding, J. P. Vaerman, and Y. Sibille. 2001. Lung mucosal immunity: immunoglobulin-A revisited. Eur. Respir. J. 18: 571-588.
25. Russell-Lodrigue, K. E., M. W. Poels, G. Q. Zhang, D. N. McMurray, and J. E. Samuel. 2005. Hepatitis associated with C. burnetii isolates. Ann. N. Y. Acad. Sci. 1063:176-180.
26. Russell-Lodrigue, K. E., G. Q. Zhang, D. N. McMurray, and J. E. Samuel. 2006. Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infect. Immun. 74:6085-6091.
27. Smith, D., E. Wiegeshaus, and V. Balasubramanian. 2000. Animal models for experimental tuberculosis. Clin. Infect. Dis. 31(Suppl. 3):S68-S70.
28. Tobias, L., D. O. Cordes, and G. G. Schurig. 1993. Placental pathology of the pregnant mouse inoculated with Brucella abortus strain 2308. Vet. Pathol. 30:119-129.
29. Van De Verg, L. L., A. B. Hartman, A. K. Bhattacharjee, B. D. Tall, L. Yuan, K. Sasala, T. L. Hadfield, W. D. Zollinger, D. L. Hoover, and R. L. Warren. 1996. Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models. Infect. Immun. 64:5263-5268.
30. Wiegeshaus, E. H., D. N. McMurray, A. A. Grover, G. E. Harding, and D. W. Smith. 1970. Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am. Rev. Respir. Dis. 102:422-429.
31. Yagupsky, P., and E. J. Baron. 2005. Laboratory exposures to brucellae and implications for bioterrorism. Emerg. Infect. Dis. 11:1180-1185.